共 50 条
- [2] Real-World Treatment Persistence Among Advanced Therapy-Experienced Patients With Ulcerative Colitis Initiated on Ustekinumab or Adalimumab [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (12S): : S23 - S23
- [6] Comparison of Real-World Healthcare Resource Utilization Among Advanced Therapy-Experienced Patients With Ulcerative Colitis Initiated on Ustekinumab or Vedolizumab [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (12S): : S15 - S15